| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/06/2002 | EP1183352A1 Vascular endothelial growth factor variants |
| 03/06/2002 | EP1183351A1 Phospholipid transfer protein |
| 03/06/2002 | EP1183350A2 Expression products of genes involved in diseases related to cholesterol metabolism |
| 03/06/2002 | EP1183349A1 Tumor-associated antigen (c42) |
| 03/06/2002 | EP1183348A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 03/06/2002 | EP1183346A1 Method for generating split, non-transferable genes that are able to express an active protein product |
| 03/06/2002 | EP1183345A2 Directed evolution of microorganisms |
| 03/06/2002 | EP1183332A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| 03/06/2002 | EP1183330A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN |
| 03/06/2002 | EP1183273A1 C-cam as an angiogenesis inhibitor |
| 03/06/2002 | EP1183272A2 49 human secreted proteins |
| 03/06/2002 | EP1183271A1 Polymer conjugates of hedgehog proteins and uses |
| 03/06/2002 | EP1183270A2 Novel organic anion transport proteins |
| 03/06/2002 | EP1183269A1 Attenuated microorganisms for the treatment of infection |
| 03/06/2002 | EP1183268A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 03/06/2002 | EP1183267A1 Retro-inverso peptides derived from interleukin-6 |
| 03/06/2002 | EP1183266A1 Retro-inverso peptides derived from leukemia inhibitory factor |
| 03/06/2002 | EP1183051A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 03/06/2002 | EP1183041A2 Ligand for cd7, and methods for use thereof |
| 03/06/2002 | EP1183040A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 03/06/2002 | EP1182924A2 TRANSGENIC MOUSE HAVING A LacZ REPORTER GENE UNDER THE CONTROL OF THE N-CAM PROMOTER USEFUL FOR IDENTIFYING N-CAM MODULATORS, METHODS AND COMPOSITIONS |
| 03/06/2002 | EP0910623A4 Thrombin receptor modified transgenic animals |
| 03/06/2002 | EP0736100B1 Recombinant protein production in bovine adenovirus expression vector system |
| 03/06/2002 | EP0723551B1 Hapten-marked peptides |
| 03/06/2002 | EP0703784B1 Release and mobilisation of haematopoietic cells |
| 03/06/2002 | EP0584201B1 Transmission-blocking vaccine against malaria |
| 03/06/2002 | CN1339107A Method of identifying N-terminal proBNP |
| 03/06/2002 | CN1339068A Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1339065A Method for preparing highly pure albumin solution |
| 03/06/2002 | CN1338943A Use of VEGF-C or VEGF-D gene or protein to prevent resitenosis |
| 03/06/2002 | CN1338473A Fusion protein with angiogenesis suppression action |
| 03/06/2002 | CN1338472A Polypeptide-human zinc finger protein 75.68 and polynucleotide for coding it |
| 03/06/2002 | CN1338471A Polypeptide-human rhamnose bound lectin 38.06 and polynucleotide for coding it |
| 03/06/2002 | CN1338470A Polypeptide-human myofibre protein 9.35 and polynucleotide for coding it |
| 03/06/2002 | CN1338469A Polypeptide-human l1 factor ORF2 associated protein 10.45 and polynucleotide for coding it |
| 03/06/2002 | CN1338468A Polypeptide-human arylhydrocarbon receptor protein 15.75 and polynucleotide for coding it |
| 03/06/2002 | CN1338467A Polypeptide-human gas vacuole protein GVPc 10.23 and polynucleotide for coding it |
| 03/06/2002 | CN1338466A Polypeptide with alpha-galactosidase activity and its coding nucleic acid |
| 03/06/2002 | CN1338465A Polypeptide-alpha-catenin 10.34 and polynucleotide for coding it |
| 03/06/2002 | CN1338464A Polypeptide-MEN2 associated FBRNP protein 9.79 and polynucleotide for coding it |
| 03/06/2002 | CN1338463A Method for improving stability of polypeptide in body and its application |
| 03/06/2002 | CN1338310A Epitope vaccine of hog cholera virus and its preparing process |
| 03/06/2002 | CN1338309A Synthetic peptide vaccine of hog cholera and its preparing process |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080310C Antibiotic wap-8294A, method for preparing the same and antibacterical composition |
| 03/06/2002 | CN1080308C Antikanamycin gene originated from microbe |
| 03/06/2002 | CN1080306C Adjusting and controlling factor for expression of nitrile solution deenzyme and gene thereof |
| 03/06/2002 | CN1080305C Preparation of hepatocellular cearcinoma oncogene |
| 03/06/2002 | CN1080304C Method for preparing modified L-protein for hepatitis B virus |
| 03/06/2002 | CN1080303C Antimicrobial proteins |
| 03/06/2002 | CN1080302C Root knot nematode resistance |
| 03/06/2002 | CN1080301C Process for purifying recombinant human serum albumin |
| 03/06/2002 | CN1080127C Ternary radiopharmaceutical complexes |
| 03/06/2002 | CN1080124C Pneumococcal polysaccharide conjugate vaccine |
| 03/06/2002 | CN1080123C Prolonged delivery of peptides |
| 03/06/2002 | CN1080094C Frozen food with antifreezer peptides and preparation thereof |
| 03/05/2002 | US6353153 Enhanced transport with a plastid membrane transport protein |
| 03/05/2002 | US6353152 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 03/05/2002 | US6353151 Transgenic model for heart failure |
| 03/05/2002 | US6353098 Synthesis, deprotection, analysis and purification of RNA and ribozymes |
| 03/05/2002 | US6353097 Nucleic acids encoding signal transduction inhibitors of allergic reactions |
| 03/05/2002 | US6353093 gidB |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6353091 A polypeptide; therapy and diagnosis of diseases, strokes, neuropathic pain and traumatic brain injury |
| 03/05/2002 | US6353090 Synthesizing an argenine-glycine-aspartate amino acid ligand with a chemical structure to restrict the conformational stereochemical structure; therapy for thrombosis, metastasis, inflammation, wound healing and rejection of prosthetics |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6352973 Polypeptides with amino acid sequences |
| 03/05/2002 | US6352972 Enhancing bone growth in mammals with bone morphogenic fusion protein |
| 03/05/2002 | US6352971 Polypeptides with amino acid sequences |
| 03/05/2002 | US6352857 Treatment of diabetes with synthetic beta cells |
| 03/05/2002 | US6352843 YsxC from Staphylococcus aureus |
| 03/05/2002 | US6352842 Exonucease-mediated gene assembly in directed evolution |
| 03/05/2002 | US6352840 pskG |
| 03/05/2002 | US6352833 Methods for discovery of vasoactive compounds for the nitric oxide-cyclic GMP signal pathway |
| 03/05/2002 | US6352831 Glycolipid complexes and their uses |
| 03/05/2002 | US6352830 Identify immunosuppressive agents by obtaining cells having a transcription factor and expose the cells to a agent that induces nuclear translocation of the transcription factor; monitor translocation and identify immunosuppressive agents |
| 03/05/2002 | US6352824 Redox reversible bipyridyl-osmium complex conjugates |
| 03/05/2002 | US6352723 Homogenate containing alkali soluble active factor which inhibits antigen-stimulated lymphocyte proliferation but intensifies with mitogen-stimulated proliferation |
| 03/05/2002 | US6352696 Viral capsomeres; vaccines; gene expression, genetic engineering |
| 03/05/2002 | US6352694 Immunotherapy; biochemical immobilization; genetic engineering; medical diagnosis |
| 03/05/2002 | CA2356553A1 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/05/2002 | CA2191971C Pegylation reagents and compounds formed therewith |
| 03/05/2002 | CA2145290C Methods and compositions for controlling translation of hcv proteins |
| 03/05/2002 | CA2079463C Live vaccines |
| 03/05/2002 | CA1341345C Expression of foreign genes in drosophila cells |
| 02/28/2002 | WO2002016655A2 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 02/28/2002 | WO2002016646A1 Haplotypes of the il1rl1lg gene |
| 02/28/2002 | WO2002016644A1 Inhibition of protein-protein interaction |
| 02/28/2002 | WO2002016633A2 Methods for identifying inhibitors of ubiquitin-mediated proteolysis of ikb |
| 02/28/2002 | WO2002016631A1 Haplotypes of the ifng gene |
| 02/28/2002 | WO2002016623A1 Bacterial strains, genes and enzymes for control of bacterial diseases by quenching quorum-sensing signals |
| 02/28/2002 | WO2002016621A2 Constitutive promoter from arabidopsis |
| 02/28/2002 | WO2002016613A2 PEAR GENES CODIFYING FOR β-GALACTOSIDASE, PECTIN METHYLESTERASE, POLYGALACTURONASE, EXPANSINS AND THEIR USE |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016607A1 Novel g protein-coupled receptor protein and dna thereof |
| 02/28/2002 | WO2002016603A2 23228, a novel human tetraspanin family member and uses thereof |
| 02/28/2002 | WO2002016600A2 Novel proteins and nucleic acids encoding same |
| 02/28/2002 | WO2002016599A2 Proteins and nucleic acids encoding same |